← Back to Search

Vitamin D + fish oil for Aging

Phase 3

Waitlist Available

Led By Yanbin Dong, MD, PhD

Research Sponsored by Augusta University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 years

Awards & highlights

All Individual Drugs Already Approved

Pivotal Trial

Summary

This trial is testing if vitamin D3 and fish oil supplements can reduce the risk of cancer, heart disease, and stroke in healthy adults. Fish oil has been studied for its potential benefits for heart health, with mixed results. The study also examines if these supplements can slow down the shortening of telomeres, which could help people stay healthier as they age.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Changes in telomere length

Secondary study objectives

Changes in Inflammation markers

Awards & Highlights

All Individual Drugs Already Approved

Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

Pivotal Trial

The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

4Treatment groups

Active Control

Placebo Group

Group I: Vitamin D + fish oilActive Control2 Interventions

Dietary supplement: Vitamin D3 (cholecalciferol), 2000 IU per day. Drug: Omega-3 fatty acids (fish oil), Omacor, 1 capsule per day. Each capsule contains 840 mg of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid (EPA) and 375 mg of docosahexaenoic acid (DHA).

Group II: Vitamin D placebo + fish oilActive Control1 Intervention

Drug: Omega-3 fatty acids (fish oil), Omacor, 1 capsule per day. Dietary supplement: Vitamin D3 placebo

Group III: Vitamin D + fish oil placeboActive Control1 Intervention

Dietary supplement: Vitamin D3 (cholecalciferol), 2000 IU per day. Dietary supplement: Fish oil placebo

Group IV: Vitamin D placebo + fish oil placeboPlacebo Group2 Interventions

Dietary supplement: Vitamin D3 placebo Dietary supplement: Fish oil placebo

0 / 1Eligibility criteria met